Human Microbiome Therapeutics Market - By Disease (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers), By Sequencing Technology Type (Targeted Gene, RNA, Whole-Genome Shotgun (WGS)) And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $4000.00 | Pages : 181 | Published : December 2020 | | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Human Microbiome Therapeutics Market Definition

The human microbiome therapeutics market consists of sales of microbiome and related services used as immunotherapeutic agents in the pharmaceutical industry. Microbiomes are used as immunotherapy for a wide variety of conditions, including infectious diseases, endocrine & metabolic disorders, inflammatory conditions, cancers, irritable bowel syndrome, neurological disorders, hematological disorders and cardiovascular diseases.

The microbiome consists of the genetic material within a microbiota, which is the collection of microorganisms, such as bacteria, archaea, fungi, and viruses, in a specific niche, such as the human gut. For example, the gut microbiome consists of collective genome of microbes inhabiting the gut. Microbiomes are also known as the metagenome of the microbiota.

Human Microbiome Therapeutics Market Size

The global human microbiome therapeutics market is expected to reach a value of nearly $148.6 million in 2025, having increased at a compound annual growth rate (CAGR) of 21.9% since 2023. The market is expected to increase from $148.6 million in 2025 to $400.0 million in 2030 having increasing at growth rate of 21.9%. Growth is forecast period is expected to drive by increase in funding, increase in prevalence of chronic diseases and technological advances. Factors that could hinder the growth of the human microbiome therapeutics market in the future include ethical issues associated with the market.

Human Microbiome Therapeutics Market Drivers

The key drivers on the human microbiome therapeutics market include:

Technological Advances

Technology is expected to be a continued driver of market growth during this period. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. Technological advances in next-generation sequencing and metagenomics have increased the feasibility of analyzing the entire human human microbiome therapeutics. These advances have made it possible to culture the human microbiota, isolate, and identify the anaerobes.  Besides, the application of cutting-edge technologies, including the anaerobic co-culture system, metagenomics, transcriptomics and proteomics, is providing major insights into the complexity of relationships between the human microbiome therapeutics and host health and diseases. These technological advances will drive the market for human microbiome therapeutics going forward.

Human Microbiome Therapeutics Market Restraints

The key restraints on the human microbiome therapeutics market include:

Ethical Concerns Related To Genomic Study

Ethical concerns related to genetic research are expected to restrain the growth of the human microbiome therapeutics market during the forecast period. There are many ethical concerns relating to the use of next generation sequencing technology due to several factors such as privacy, informed consent, and return of results, among others.  These ethical concerns might have a negative impact on the growth of the human microbiome therapeutics market

Human Microbiome Therapeutics Market Trends

Major trends influencing the human microbiome therapeutics market include:

Strategic Collaborations And Agreements

Companies in the human microbiome therapeutics market are strategically partnering and collaborating with other companies to broaden their product portfolios and expand their human microbiome therapeutics therapeutics business. For instance, in November 2019, Enterome, a France-based leading player in the human microbiome therapeutics market entered into collaboration with Memorial Sloan Kettering Cancer Canter (MSK), a US-based research institute to develop cancer immunotherapies from gut human microbiome therapeutics-derived antigens.  Also, in 2018, Microbiotica, a leading player in the market entered into a collaboration with Genentech to develop human microbiome therapeutics therapeutics to treat inflammatory bowel disease.

Increasing Number Of Pipeline Studies And Drug Development

Companies in the human microbiome therapeutics market and research institutes are increasing the number of pipeline studies to develop anti-viral drugs for treating many disease conditions. Companies have also started investing in startups and other early-stage companies to develop pipelines for treating different diseases. Also, in 2018, Microbiotica, a leading player in the market entered into a collaboration with Genentech to develop human microbiome therapeutics therapeutics pipeline to treat inflammatory bowel disease. In June 2020, Debiopharm, a Switzerland-based biopharmaceutical company announced its research collaboration with Takeda Pharmaceuticals, to develop human microbiome therapeutics therapeutics to treat gastrointestinal disorders.

Opportunities And Recommendations In The Human Microbiome Therapeutics Market

Opportunities – The top opportunities in the human microbiome therapeutics market segmented by disease will arise in the infectious disease segment, which will gain $183.5 million of global annual sales by 2030. The top opportunities in the human microbiome therapeutics market segmented by sequencing technology type will arise in the whole-genome shotgun market segment, which will gain $115.2 million of global annual sales by 2030.

Market-trend-based strategies for the human microbiome therapeutics market include investing in the strategic collaboration and research and development of human microbiome therapeutics therapeutics for treating cancers. Player-adopted strategies in the human microbiome therapeutics market include expanding through strategic collaborations.

Recommendations – To take advantage of the opportunities, the business research company recommends the human microbiome therapeutics market companies to focus on strategic collaborations and agreements, focus on pipeline studies and drug development, focus on increasing investments for development of cancer human microbiome therapeutics therapeutics, establish operations in emerging markets, leverage online pharmacies, set up authorized distributors and sales representatives, provide competitively priced offerings in low-income countries to reach new users, offer skimmed pricing for innovative drugs, participate in trade shows and events, increase adoption of the internet and social media, target local pharmacies to spread awareness, focus on digestive health and focus on the increased requirement of R&D scientists

Human Microbiome Therapeutics Market Segmentation

The human microbiome therapeutics market is segmented by disease, by sequencing technology type, by geography.
By Disease - The human microbiome therapeutics market can be segmented by disease into
    • a. Infectious Diseases
    • b. Gastrointestinal Disorders
    • c. Metabolic Disorders
    • d. Cancers
    • e. Other Diseases
The infectious diseases market was the largest segment of the human microbiome therapeutics market segmented by disease, accounting for 70.9% of the total in 2030. It is also expected to be the fastest growing segment in the human microbiome therapeutics market segmented by disease, at a CAGR of 15.7% during 2025-2030.
By Sequencing Technology Type - The human microbiome therapeutics market can be segmented by sequencing technology type into
    • a. Targeted Gene
    • b. RNA
    • c. Whole-Genome Shotgun (WGS)
    • d. Others Type
The global RNA market was the largest segment of the human microbiome therapeutics market segmented by sequencing technology type, accounting for 32.5% of the total in 2023. Going forward, the whole genome shotgun segment is expected to be the fastest growing segment in the human microbiome therapeutics market segmented by sequencing technology type, going forward, at a CAGR of 18.2% during 2025-2030.
By Geography- The human microbiome therapeutics market is segmented into
    • o North America
      • USA
    • o Western Europe
      • UK
      • Germany
      • France
    • o Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • Indonesia
      • South Korea
    • o Eastern Europe
      • Russia
    • o South America
      • Brazil
    • o Middle East
    • o Africa
North America was the largest region in the global human microbiome therapeutics market, accounting for 52.8% of the total in 2030. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the human microbiome therapeutics market will be Asia Pacific and North America where growth will be at CAGRs of 47.4% and 21.6% respectively. These will be followed by Eastern Europe, and South America, where the markets are expected to grow at CAGRs of 19.3% and 15.6% respectively.

Human Microbiome Therapeutics Competitive Landscape

Major Competitors are:
    • • Seres Therapeutics
    • • Assembly Biosciences
    • • Enterome Bioscience
    • • Vedanta BioSciences
    • • Second Genome Inc
Other Competitors Include:
    • • ViThera Pharmaceuticals Inc.
    • • Osel
    • • Rebiotix, Inc
    • • MicroBiome Therapeutics LLC
    • • MaaT Pharma
    • • Kallyope
    • • Finch Therapeutics
    • • Concentric
    • • AOBiome
    • • Enterome
    • • Yakult Honsha Co., Ltd
    • • Metabiomics Corporate
    • • Synthetic Biologics, Inc.
    • • DuPont
    • • BiomX Ltd
    • • EnteroBiotix
    • • Microbiotica
    • • Juni Bio
    • • OptiBiotix
    • • Eligo Bioscience
    • • SNIPR Biome
    • • Ritter Pharmaceuticals
    • • OpenBiome
    • • Human Microbiome Therapeutics Insights Inc.
    • • Yeda Research and Development Co. Ltd
    • • DayTwo
    • • MyBiome

    Table Of Contents

    1. Human Microbiome Therapeutics Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    7. Human Microbiome Therapeutics Market Characteristics

    7.1. Market Definition

    7.2. Segmentation By Disease

    7.2.1. Infectious Diseases

    7.2.2. Gastrointestinal Disorders

    7.2.3. Metabolic Disorders

    7.2.4. Cancers

    7.2.5. Other Diseases

    7.3. Segmentation By Sequencing Technology Type

    7.3.1. Targeted Gene

    7.3.2. RNA

    7.3.3. Whole-Genome Sequencing (WGS)- Shotgun

    7.3.4. Others Types

    8. Human Microbiome Therapeutics Market Trends And Strategies

    8.1. Strategic Collaborations And Agreements

    8.2. Increasing Number Of Pipeline Studies And Drug Development

    8.3. Increasing Investments On Development Of Cancer Microbiome Therapeutics

    9. COVID Impact Human Microbiome Therapeutics Market

    10. Global Human Microbiome Therapeutics Market Size And Growth

    10.1. Forecast Market Growth, 2023 – 2030, Value ($ Million)

    10.1.1. Drivers Of The Market 2023 – 2030

    10.1.2. Restraints On The Market 2023 – 2030

    11. Human Microbiome Therapeutics Market, Regional Analysis

    11.1. Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 – 2030, Value ($ Million)

    11.2. Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 – 2030, Value ($ Million)

    12. Global Human Microbiome Therapeutics Market Segmentation

    12.1. Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    12.1.1. Infectious Diseases

    12.1.2. Cancers

    12.1.3. Gastrointestinal Disorders

    12.1.4. Metabolic Disorders

    12.2. Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 – 2030, Value ($ Million)

    12.2.1. Targeted Gene

    12.2.2. RNA

    12.2.3. Whole-genome Shotgun

    12.2.4. Other Type

    13. Asia-Pacific Human Microbiome Therapeutics Market

    13.1. Asia-Pacific Human Microbiome Therapeutics Market Overview

    13.1.1. Region Information

    13.1.2. Impact of COVID-19

    13.1.3. Market Information

    13.1.4. Background Information

    13.1.5. Government Initiatives

    13.1.6. Regulations

    13.1.7. Regulatory Bodies

    13.1.8. Major Associations

    13.1.9. Taxes Levied

    13.1.10. Corporate Tax Structure

    13.1.11. Investment

    13.1.12. Major Companies

    13.2. Asia-Pacific Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    13.3. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    13.4. Asia-Pacific Human Microbiome Therapeutics Market: Country Analysis

    13.5. China Human Microbiome Therapeutics Market

    13.6. China Human Microbiome Therapeutics Market Overview

    13.6.1. Country Information

    13.6.2. Impact of COVID-19

    13.6.3. Market Information

    13.6.4. Background Information

    13.6.5. Regulations

    13.6.6. Regulatory Bodies

    13.6.7. Major Associations

    13.6.8. Corporate Tax Structure

    13.6.9. Investment

    13.6.10. Major Companies

    13.7. China Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    13.8. China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    13.9. India Human Microbiome Therapeutics Market

    13.10. India Human Microbiome Therapeutics Market Overview

    13.10.1. Country Information

    13.10.2. Impact of COVID-19

    13.10.3. Market Information

    13.10.4. Background Information

    13.10.5. Government Initiatives

    13.10.6. Regulations

    13.10.7. Regulatory Bodies

    13.10.8. Major Associations

    13.10.9. Corporate Tax Structure

    13.10.10. Major Companies

    13.11. India Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    13.12. India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    13.13. Japan Human Microbiome Therapeutics Market

    13.14. Japan Human Microbiome Therapeutics Market Overview

    13.14.1. Country Information

    13.14.2. Impact of COVID-19

    13.14.3. Market Information

    13.14.4. Background Information

    13.14.5. Regulations

    13.14.6. Regulatory Bodies

    13.14.7. Corporate Tax Structure

    13.14.8. Investment

    13.14.9. Major Companies

    13.15. Japan Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    13.16. Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    13.17. Australia Human Microbiome Therapeutics Market

    13.18. Australia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    13.19. Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    13.20. Indonesia Human Microbiome Therapeutics Market

    13.21. Indonesia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    13.22. Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    13.23. South Korea Human Microbiome Therapeutics Market

    13.24. South Korea Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    13.25. South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    14. Western Europe Human Microbiome Therapeutics Market

    14.1. Western Europe Human Microbiome Therapeutics Market Overview

    14.1.1. Region Information

    14.1.2. Impact Of COVID-19

    14.1.3. Market Information

    14.1.4. Background Information

    14.1.5. Government initiatives

    14.1.6. Regulations

    14.1.7. Regulatory Bodies

    14.1.8. Major Associations

    14.1.9. Taxes Levied

    14.1.10. Corporate Tax Structure

    14.1.11. Investment

    14.1.12. Major Companies

    14.2. Western Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    14.3. Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    14.4. Western Europe Human Microbiome Therapeutics Market: Country Analysis

    14.5. UK Human Microbiome Therapeutics Market

    14.6. UK Human Microbiome Therapeutics Market Overview

    14.6.1. Country Information

    14.6.2. Impact Of COVID-19

    14.6.3. Market Information

    14.6.4. Background Information

    14.6.5. Government Initiatives

    14.6.6. Regulations

    14.6.7. Regulatory Bodies

    14.6.8. Major Associations

    14.6.9. Taxes Levied

    14.6.10. Corporate Tax Structure

    14.6.11. Investment

    14.6.12. Major Companies

    14.7. UK Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    14.8. UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    14.9. Germany Human Microbiome Therapeutics Market

    14.10. Germany Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    14.11. Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    14.12. France Human Microbiome Therapeutics Market

    14.13. France Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    14.14. France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    15. Eastern Europe Human Microbiome Therapeutics Market

    15.1. Eastern Europe Human Microbiome Therapeutics Market Overview

    15.1.1. Region Information

    15.1.2. Impact Of COVID-19

    15.1.3. Market Information

    15.1.4. Background Information

    15.1.5. Government Initiatives

    15.1.6. Regulations

    15.1.7. Regulatory Bodies

    15.1.8. Major Associations

    15.1.9. Taxes Levied

    15.1.10. Corporate Tax Structure

    15.1.11. Investments

    15.1.12. Major Companies

    15.2. Eastern Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    15.3. Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    15.4. Eastern Europe Human Microbiome Therapeutics Market: Country Analysis

    15.5. Russia Human Microbiome Therapeutics Market

    15.6. Russia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    15.7. Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    16. North America Human Microbiome Therapeutics Market

    16.1. North America Human Microbiome Therapeutics Market Overview

    16.1.1. Region Information

    16.1.2. Impact Of COVID-19

    16.1.3. Market Information

    16.1.4. Background Information

    16.1.5. Government Initiatives

    16.1.6. Regulations

    16.1.7. Regulatory Bodies

    16.1.8. Major Associations

    16.1.9. Taxes Levied

    16.1.10. Corporate Tax Structure

    16.1.11. Investment

    16.1.12. Major Companies

    16.2. North America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    16.3. North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    16.4. North America Human Microbiome Therapeutics Market: Country Analysis

    16.5. USA Human Microbiome Therapeutics Market

    16.6. USA Human Microbiome Therapeutics Market Overview

    16.6.1. Country Information

    16.6.2. Impact Of COVID-19

    16.6.3. Market Information

    16.6.4. Background Information

    16.6.5. Government Initiatives

    16.6.6. Regulations

    16.6.7. Regulatory Bodies

    16.6.8. Major Associations

    16.6.9. Corporate Tax Structure

    16.6.10. Investments

    16.6.11. Major Companies

    16.7. USA Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    16.8. USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    17. South America Human Microbiome Therapeutics Market

    17.1. South America Human Microbiome Therapeutics Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. Impact Of COVID-19

    17.1.4. Background Information

    17.1.5. Government Initiatives

    17.1.6. Regulations

    17.1.7. Regulatory Bodies

    17.1.8. Major Associations

    17.1.9. Taxes Levied

    17.1.10. Corporate Tax Structure

    17.1.11. Investments

    17.1.12. Major Companies

    17.2. South America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    17.3. South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    17.4. South America Human Microbiome Therapeutics Market: Country Analysis

    17.5. Brazil Human Microbiome Therapeutics Market

    17.6. Brazil Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    17.7. Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    18. Middle East Human Microbiome Therapeutics Market

    18.1. Middle East Human Microbiome Therapeutics Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. Impact Of COVID-19

    18.1.4. Background Information

    18.1.5. Government Initiatives

    18.1.6. Regulations

    18.1.7. Regulatory Bodies

    18.1.8. Major Associations

    18.1.9. Taxes Levied

    18.1.10. Corporate Tax Structure

    18.1.11. Investments

    18.1.12. Major Companies

    18.2. Middle East Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    18.3. Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    19. Africa Human Microbiome Therapeutics Market

    19.1. Africa Human Microbiome Therapeutics Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Impact Of COVID-19

    19.1.4. Background Information

    19.1.5. Government Initiatives

    19.1.6. Regulations

    19.1.7. Regulatory Bodies

    19.1.8. Major Associations

    19.1.9. Taxes Levied

    19.1.10. Corporate Tax Structure

    19.1.11. Investments

    19.1.12. Major Companies

    19.2. Africa Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 – 2030, Value ($ Million)

    19.3. Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, Value ($ Million)

    20. Global Human Microbiome Therapeutics Market Competitive Landscape

    20.1. Company Profiles

    20.2. Seres Therapeutics

    20.2.1. Company Overview

    20.2.2. Products And Services

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    20.3. Assembly Biosciences

    20.3.1. Company Overview

    20.3.2. Products And Services

    20.3.3. Business Strategy

    20.3.4. Financial Overview

    20.4. Enterome Bioscience

    20.4.1. Company Overview

    20.4.2. Products And Services

    20.4.3. Business Strategy

    20.4.4. Financial Overview

    20.5. Vedanta BioSciences

    20.5.1. Company Overview

    20.5.2. Products And Services

    20.5.3. Business Strategy

    20.5.4. Financial Overview

    20.6. Second Genome Inc.

    20.6.1. Company Overview

    20.6.2. Products And Services

    20.6.3. Business Strategy

    20.6.4. Financial Overview

    21. Key Mergers And Acquisitions In The Human Microbiome Therapeutics Market

    21.1. Janssen Collaborated With Kaleido Biosciences

    21.2. Ritter Pharmaceuticals Merged With Qualigen, Inc.

    21.3. Ferring Pharmaceuticals Acquired Rebiotix

    21.4. Monsanto Collaborated With Second Genome

    22. Human Microbiome Therapeutics Market Opportunities And Strategies

    22.1. Global Human Microbiome Therapeutics Market In 2030 – Countries Offering Most New Opportunities

    22.2. Global Human Microbiome Therapeutics Market In 2030 – Segments Offering Most New Opportunities

    22.3. Global Human Microbiome Therapeutics Market In 2023 – Growth Strategies

    22.3.1. Market Trend Based Strategies

    22.3.2. Competitor Strategies

    23. Microbiome Homes Market, Conclusions And Recommendations

    23.1. Conclusions

    23.2. Recommendations

    23.2.1. Product

    23.2.2. Place

    23.2.3. Price

    23.2.4. Promotion

    23.2.5. People

    24. Appendix

    24.1. Market Data Sources

    24.2. Research Methodology

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    24.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 2:  Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 – 2030, %
  • Table 3:  Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 – 2030, $ Million
  • Table 4:  Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 – 2030, %
  • Table 5:  Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 – 2030, $ Million
  • Table 6: Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 7: Global Human Microbiome Therapeutics Market, Segmentation By Disease,  Forecast, 2023 – 2030, $ Million
  • Table 8: Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 – 2030, %
  • Table 9: Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 – 2030, $ Million
  • Table 12: Asia Pacific Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 13: Asia Pacific Oncology Drugs Market, 2015-2019, $ Billion
  • Table 14: Asia Pacific Gastrointestinal Market, 2015-2019, $ Billion
  • Table 15: Asia Pacific Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 16: Asia-Pacific Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 17: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 18: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 19: China Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 20: China Oncology Drugs Market, 2015-2019, $ Billion
  • Table 21: China Gastrointestinal Market, 2015-2019, $ Billion
  • Table 22: China Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 23: China Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 24: China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 25: China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 26: India Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 27: India Oncology Drugs Market, 2015-2019, $ Billion
  • Table 28: India Gastrointestinal Market, 2015-2019, $ Billion
  • Table 29: India Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 30: India Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 31: India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 32: India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 33: Japan Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 34: Japan Oncology Drugs Market, 2015-2019, $ Billion
  • Table 35: Japan Pacific Gastrointestinal Market, 2015-2019, $ Billion
  • Table 36: Japan Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 37: Japan Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 38: Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 39: Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 40: Australia Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 41: Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 42: Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 43: Indonesia Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 44: Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 45: Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 46: South Korea Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 47: South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 48: South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 49: Western Europe Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 50: Western Europe Oncology Drugs Market, 2015-2019, $ Billion
  • Table 51: Western Europe Gastrointestinal Market, 2015-2019, $ Billion
  • Table 52:Western Europe Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 53: Western Europe Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 54: Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 55: Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 56: UK Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 57: UK Oncology Drugs Market, 2015-2019, $ Billion
  • Table 58: UK Gastrointestinal Market, 2015-2019, $ Billion
  • Table 59: UK Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 60: UK Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 61: UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 62: UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 63: Germany Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 64: Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 65: Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 66: France Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 67: France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 68: France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 69: Eastern Europe Metabolic Drugs Market, 2015-2019, $ Billion
  • Table 70: Eastern Europe Oncology Drugs Market, 2015-2019, $ Billion
  • Table 71: Eastern Europe Gastrointestinal Market, 2015-2019, $ Billion
  • Table 72:Eastern  Europe Anti-infective Drugs Market, 2015-2019, $ Bllion
  • Table 73: Eastern Europe Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 74: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 75: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 76: Russia Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 77: Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 78: Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 79: North America Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 80: North America Oncology Drugs Market, 2015-2019, $ Billion
  • Table 81: North America Gastrointestinal Market, 2015-2019, $ Billion
  • Table 82: North America Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 83: North America Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 84: North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 85: North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 86: USA Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 87: USA Oncology Drugs Market, 2015-2019, $ Billion
  • Table 88: USA Gastrointestinal Market, 2015-2019, $ Billion
  • Table 89: USA Anti-infective Drugs Market, 2015-2019, $ Bullion
  • Table 90: USA Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 91: USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 92: USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 93: South America Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 94: South America Oncology Drugs Market, 2015-2019, $ Billion
  • Table 95: South America Gastrointestinal Market, 2015-2019, $ Billion
  • Table 96: South America Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 97: South America Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 98: South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 99: South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 100: Brazil Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 101: Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 102: Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 103: Middle East Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 104: Middle East Oncology Drugs Market, 2015-2019, $ Billion
  • Table 105: Middle East Gastrointestinal Market, 2015-2019, $ Billion
  • Table 106: Middle East Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 107: Middle East Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 108: Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 109: Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 110: Africa Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 111: Africa Oncology Drugs Market, 2015-2019, $ Billion
  • Table 112: Africa Gastrointestinal Market, 2015-2019, $ Billion
  • Table 113: Africa Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 114: Africa Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Table 115: Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Table 116: Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, $ Million
  • Table 117: Global Human Microbiome Therapeutics Market, Key Competitor Estimated Ranks, 2019
  • Table 118: Seres Therapeutics – Financial Performance, 2016 – 2019, $ Billion
  • Table 119: Global Human Microbiome Therapeutics Market Size Gain ($ Million), 2023 – 2030, By Country
  • Table 120: Global Human Microbiome Therapeutics Market Size Gain ($ Million), Segmentation By Disease, 2023 – 2030
  • Table 121: Global Human Microbiome Therapeutics Market Size Gain ($ Million), Segmentation By Sequencing Technology Type, 2023 – 2030
  • Table 122: Human Microbiome Therapeutics Market Data Sources

List Of Figures

    Figure 1: Global Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 2: Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 – 2030, %
  • Figure 3: Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 – 2030, %
  • Figure 4: Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 5: Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 – 2030, %
  • Figure 7: Asia-Pacific Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 8: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 9: China Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 10: China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 11: India Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 12: India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 13: Japan Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 14: Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 15: Australia Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 16: Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 17: Indonesia Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 18: Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 19: South Korea Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 20: South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 21: Western Europe Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 22: Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 23: UK Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 24: UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 25: Germany Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 26: Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 27: France Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 28: France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 29: Eastern Europe Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 30: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 31: Russia Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 32: Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 33: North America Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 34: North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 35: USA Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 36: USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 37: South America Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 38: South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 39: Brazil Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 40: Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 41: Middle East Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 42: Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 43: Africa Human Microbiome Therapeutics Market, Forecast, 2023 – 2030, $ Million
  • Figure 44: Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 – 2030, %
  • Figure 45: Seres Therapeutics – Financial Performance, 2016 – 2019, $ Billion
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2024 – By Drugs Type (Avastin, Tecentriq, Lucentis, Tagrisso, Cometriq, Eylea, Other Drug Types), By Route Of Administration (Oral, Intravenous, Intravitreal), By Application (Oncology, Ophthalmology, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Checkpoint Inhibitors Global Market Report 2024 – By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, Other Drugs), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma, Other Applications), By End-Users (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
TNF Alpha Inhibitors Global Market Report 2024 – By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab)), By Route Of Administration (Oral, Subcutaneous, Intravenous, Other Route Of Administration), By Disease Type (Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis, Other Disease Types) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Protein Inhibitors Global Market Report 2024 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody, Other Products), By Application (Oncology, Inflammatory Diseases, Other Applications), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
HER2 Inhibitors Global Market Report 2024 – By Treatment (Monotherapy, Combination Therapy), By Application (Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer, Other Applications), By End User (Hospitals, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Interleukin Inhibitors Global Market Report 2024 – By Type (IL-17, IL-23, IL-1, IL-5, IL-6, Other Types), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Immunosuppressants Global Market Report 2024 – By Drug Class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Nucleic Acid Based Gene Therapy Global Market Report 2024 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the human microbiome therapeutics market?

The human microbiome therapeutics market consists of sales of microbiome and related services used as immunotherapeutic agents in the pharmaceutical industry. Microbiomes are used as immunotherapy for a wide variety of conditions, including infectious diseases, endocrine & metabolic disorders, inflammatory conditions, cancers, irritable bowel syndrome, neurological disorders, hematological disorders and cardiovascular diseases. request a sample here

How will the human microbiome therapeutics market drivers and restraints affect human microbiome therapeutics market dynamics? What forces will shape the human microbiome therapeutics industry going forward?

The human microbiome therapeutics market growth is aided by technological advances. However, some human microbiome therapeutics market restraints include ethical concerns related to genomic study. request a sample here

What is the forecast market size of the human microbiome therapeutics market?

The human microbiome therapeutics market forecast is expected to reach $400.0 million in 2030 at a compound annual growth rate of 21.9%. request a sample here

How is the human microbiome therapeutics market segmented?

The global human microbiome therapeutics market is segmented-
a) By Disease -
b) By Sequencing Technology Type request a sample here

Which region has largest share, and what is the market size and growth by geography according to the human microbiome therapeutics global market report?

For more detail on this, request a sample here.

Who are the key players of the global human microbiome therapeutics market?

Top competitors in the global human microbiome therapeutics market are Seres Therapeutics.; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc. request a sample here.

What are the key trends in the global human microbiome therapeutics market?

Major trends global human microbiome therapeutics market include strategic collaborations and agreements. request a sample here.

What are the major opportunities in the human microbiome therapeutics market and the approaches companies can take to take advantage of them?

For this and further detailed insights on the market, request a sample here. request a sample here.

How does the human microbiome therapeutics market relate to the overall economy and other similar markets?

request a sample here.

request a sample here.

request a sample here.